Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002327811 | SCV002628590 | uncertain significance | Cardiovascular phenotype | 2024-08-19 | criteria provided, single submitter | clinical testing | The p.D1400N variant (also known as c.4198G>A), located in coding exon 10 of the TNXB gene, results from a G to A substitution at nucleotide position 4198. The aspartic acid at codon 1400 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV004770450 | SCV005379038 | uncertain significance | not provided | 2023-12-15 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |